-+ 0.00%
-+ 0.00%
-+ 0.00%

AURIGENE ONCOLOGY LIMITED - AUR112 ACHIEVES 63.6% RESPONSE RATE IN PHASE 1 TRIAL

Reuters·12/02/2025 13:00:01

Please log in to view news